1. How useful are body mass index and history of diabetes in COVID-19 risk stratification?
- Author
-
Salvy, Sarah-Jeanne, Datta, Geetanjali D, Yu, Qihan, Lauzon, Marie, Hussain, Shehnaz K, Cheng, Susan, Ebinger, Joseph E, Goodarzi, Mark O, and Figueiredo, Jane C
- Subjects
Epidemiology ,Health Sciences ,Patient Safety ,Infectious Diseases ,Clinical Research ,Emerging Infectious Diseases ,Diabetes ,Coronaviruses ,Obesity ,Nutrition ,Prevention ,2.4 Surveillance and distribution ,Metabolic and endocrine ,Good Health and Well Being ,Body Mass Index ,COVID-19 ,Diabetes Mellitus ,Humans ,Retrospective Studies ,Risk Assessment ,Risk Factors ,SARS-CoV-2 ,General Science & Technology - Abstract
ObjectiveThis study examines the value of risk stratification by documented diagnosis of diabetes and objectively measured height and weight (BMI) in COVID-19 severity and mortality in a large sample of patients in an urban hospital located in Southern California.MethodsData from a retrospective cohort study of COVID-19 patients treated at Cedars-Sinai Medical Center between March 8, 2020, and January 25, 2021, was analyzed. Sociodemographic characteristics and pre-existing conditions were extracted from electronic medical records. Univariable and multivariable logistic regression models identified associated risk factors, and a regression causal mediation analysis examined the role of diabetes in the association between obesity and illness severity. All analyses were stratified by age (
- Published
- 2022